UPDATE
: Thursday, December 12, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
2 orphan drugs find manufacturers in Korea
by Lee Hye-seon
2017-10-12 15:48
Roche Korea’s lung cancer drug increases cost-effectiveness
by Marian Chu
2017-10-12 14:59
Rethink obesity, says Novo Nordisk Korea
by Marian Chu
2017-10-12 11:20
AstraZeneca’s ovarian cancer drug more affordable
by Marian Chu
2017-10-11 18:14
Boryung to sell antihypertensive drugs in SE Asia
by Lee Hye-seon
2017-10-11 16:02
라인
Daewoong to sell Novartis’ osteoporosis drug
by Marian Chu
2017-10-11 11:39
Green Cross units sign MOU with Sudan Central Lab
by Lee Han-soo
2017-10-10 15:53
SK Chemicals ‘Skyzoster’ wins sales approval
by Lee Han-soo
2017-10-10 12:16
Immunotherapy developers engage in fierce competition to expand indications
by Marian Chu
2017-10-05 06:00
Dongkook Pharm, Madagascar government to develop natural medicines
by Lee Han-soo
2017-09-29 17:39
라인
AbbVie’s hepatitis C treatment approved in Japan
by Marian Chu
2017-09-29 12:03
Korea lags behind osteoporosis prevention and treatment
by Marian Chu
2017-09-29 10:21
World’s best-selling drug Humira gains insurance coverage in Korea
by Marian Chu
2017-09-28 19:02
Amgen Korea’s osteoporosis treatment gets insurance coverage
by Marian Chu
2017-09-28 19:02
Korean drugmakers’ smart factories at ‘base level’
by Nam Doo-hyun
2017-09-28 16:00
라인
Drugmakers need to differentiate big data from ‘large data’
by Nam Doo-hyun
2017-09-27 17:44
Exelixis’ kidney cancer drug gains approval in Korea
by Marian Chu
2017-09-27 17:44
Korean combos, incrementally modified drugs to get insurance benefits
by Lee Hye-seon
2017-09-27 11:29
Ilyang presents leukemia treatment’s clinical results
by Lee Han-soo
2017-09-26 17:31
Ministry changes dosage recommendation for Bayer’s blood-thinning drug
by Marian Chu
2017-09-26 16:24
-
이전
81
82
83
84
85
86
87
-
GC Labcell releases trial results of NK-cell combination treatment
Laparoscopic surgery effective in treating cancer in pancreas head
Eli Lilly Korea launches migraine prevention drug
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
GC Labcell releases trial results of NK-cell combination treatment
Laparoscopic surgery effective in treating cancer in pancreas head
Eli Lilly Korea launches migraine prevention drug
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
여백
Most viewed
1
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
2
Syntekabio, CHA Hospital to co-develop immunotherapy
3
‘Endogenous T cells have high potential of treating blood, solid tumors’
4
AbbVie’s Venclexta nears insurance benefit
5
Aprogen, 1st Korean biotech firm to win unicorn status
6
AMC unravels clues in treating relapsing, metastatic bladder cancer
7
Korea selected as 'Medical Tourism Destination of the Year'
8
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
9
AbbVie's releases new data for chronic lymphocytic leukemia treatment
10
ABL Bio unveils new bispecific antibody at US meet
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top